Dag Torfoss

521 total citations
19 papers, 286 citations indexed

About

Dag Torfoss is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Dag Torfoss has authored 19 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Internal Medicine. Recurrent topics in Dag Torfoss's work include Neutropenia and Cancer Infections (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Blood disorders and treatments (3 papers). Dag Torfoss is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Blood disorders and treatments (3 papers). Dag Torfoss collaborates with scholars based in Norway, Denmark and India. Dag Torfoss's co-authors include Peter Meyer, Egil Lingaas, Ingvild Nordøy, Erik H. Strøm, Susanne Dudman, Karin Fahl Wader, Anne Tierens, Olav Hungnes, Tone Nordøy and Olav Erich Yri and has published in prestigious journals such as Blood, Journal of Antimicrobial Chemotherapy and Journal of Thrombosis and Haemostasis.

In The Last Decade

Dag Torfoss

17 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dag Torfoss Norway	8	68	64	59	53	47	19	286
Chung Hyun Nahm South Korea	9	30 0.4×	41 0.6×	116 2.0×	4 0.1×	55 1.2×	23	337
Åke Cederberg Sweden	10	19 0.3×	24 0.4×	92 1.6×	27 0.5×	32 0.7×	19	342
Myron Brand United States	11	54 0.8×	34 0.5×	97 1.6×	7 0.1×	3 0.1×	25	420
B Fürll Germany	5	18 0.3×	22 0.3×	63 1.1×	16 0.3×	4 0.1×	7	440
Jin‐Tae Suh South Korea	10	86 1.3×	51 0.8×	114 1.9×	9 0.2×	3 0.1×	31	394
F Mohammadi Iran	14	72 1.1×	271 4.2×	268 4.5×	6 0.1×	13 0.3×	72	602
Julie Véziant France	12	238 3.5×	73 1.1×	27 0.5×	36 0.7×	27 0.6×	35	554
Sowmya Nanjappa United States	10	83 1.2×	69 1.1×	76 1.3×	3 0.1×	2 0.0×	62	306
Jinjian Fu China	14	37 0.5×	132 2.1×	185 3.1×	10 0.2×	6 0.1×	27	492
M. Carmen Fariñas Spain	10	18 0.3×	85 1.3×	100 1.7×	8 0.2×	11 0.2×	20	222

Countries citing papers authored by Dag Torfoss

Since Specialization

Citations

This map shows the geographic impact of Dag Torfoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Torfoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Torfoss more than expected).

Fields of papers citing papers by Dag Torfoss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dag Torfoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Torfoss. The network helps show where Dag Torfoss may publish in the future.

Co-authorship network of co-authors of Dag Torfoss

This figure shows the co-authorship network connecting the top 25 collaborators of Dag Torfoss. A scholar is included among the top collaborators of Dag Torfoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dag Torfoss. Dag Torfoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Enden, Tone, Herish Garresori, E Jacobsen, et al.. (2023). OC 03.5 Arterial Events in Cancer Patients Treated with Apixaban for Venous Thrombosis. Research and Practice in Thrombosis and Haemostasis. 7. 100310–100310. 1 indexed citations

Enden, Tone, Herish Garresori, E. Jacobsen, et al.. (2023). Arterial events in cancer patients treated with apixaban for venous thrombosis. Thrombosis Research. 228. 128–133. 3 indexed citations

Garresori, Herish, Tone Enden, E. Jacobsen, et al.. (2022). Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up. Journal of Thrombosis and Haemostasis. 20(5). 1166–1181. 25 indexed citations

Garresori, Herish, Eva‐Marie Jacobsen, Dag Torfoss, et al.. (2022). Arterial Thromboembolism in Cancer Patients Treated with Apixaban. Blood. 140(Supplement 1). 11366–11367.

Enden, Tone, Herish Garresori, E. Jacobsen, et al.. (2020). Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism. Thrombosis Research. 196. 238–244. 6 indexed citations

Torfoss, Dag, et al.. (2017). Kreftpasient i 50-årene med plagsom hjertebank. Tidsskrift for Den norske legeforening. 137(16). 1 indexed citations

Torfoss, Dag, Lorentz Brinch, Fredrik Schjesvold, et al.. (2016). Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial. Clinical Microbiology and Infection. 23(3). 179–187. 7 indexed citations

Fløisand, Yngvar, Lorentz Brinch, Tobias Gedde‐Dahl, et al.. (2012). Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 47(12). 1552–1557. 6 indexed citations

Yri, Olav Erich, Dag Torfoss, Olav Hungnes, et al.. (2011). Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood. 118(26). 6769–6771. 119 indexed citations

10.

Torfoss, Dag, E. Arne Høiby, Harald Holte, & Stein Kvaløy. (2011). The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review. Acta Oncologica. 51(4). 433–440. 7 indexed citations

11.

Lingaas, Egil, et al.. (2010). A large outbreak of Listeria monocytogenes infection with short incubation period in a tertiary care hospital. Journal of Infection. 61(6). 465–470. 57 indexed citations

12.

Torfoss, Dag, E. Arne Høiby, Harald Holte, & Stein Kvaløy. (2008). [Penicillin and aminoglycoside in febrile neutropenia].. PubMed. 128(23). 2738–40. 2 indexed citations

13.

Torfoss, Dag, E. Arne Høiby, Jon Magnus Tangen, et al.. (2007). Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. Journal of Antimicrobial Chemotherapy. 59(4). 711–717. 19 indexed citations

14.

Sivertsen, Einar Andreas & Dag Torfoss. (2004). [Cryptococcal meningitis].. PubMed. 124(1). 28–30. 1 indexed citations

15.

Torfoss, Dag & Tore G. Abrahamsen. (2000). Salmonellasmitte fra skilpadder. Tidsskrift for Den Norske Laegeforening. 2 indexed citations

16.

Torfoss, Dag & Tore G. Abrahamsen. (2000). [Salmonella infection from turtles].. PubMed. 120(30). 3670–1. 5 indexed citations

17.

Torfoss, Dag, et al.. (1999). Carrier rate of resistant enterococci in a tertiary care hospital in Norway. Apmis. 107(1-6). 545–549. 8 indexed citations

18.

Torfoss, Dag. (1998). Cardiac tamponade preceding adrenal insufficiency – an unusual presentation of Addison's disease. Journal of Internal Medicine. 243(5). 399–400. 2 indexed citations

19.

Torfoss, Dag, et al.. (1997). Cardiac tamponade preceding adrenal insufficiency ‐ an unusual presentation of Addisons's disease: a report of two cases.. Journal of Internal Medicine. 241(6). 525–528. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact